On March 15, 2016, Eric W. Fangmann notified Capstone Therapeutics Corp. that, effective immediately, he was resigning from the company's Board of Directors and the company's Audit Committee. Eric W. Fangmann has served as a director of the company since being elected by Stockholders on June 12, 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | -.--% | -35.00% | -.--% |
Apr. 01 | Capstone Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Capstone Holding Corp. Announces Change in Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 820K | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- CAPS Stock
- News Capstone Holding Corp.
- Capstone Therapeutics Corp. Announces Resignation of Eric W. Fangmann from the Board of Directors and Audit Committee